149 | FIRST‐IN‐HUMAN PHASE 1 STUDY OF DR‐01, A NON‐FUCOSYLATED ANTI‐CD94 ANTIBODY IN PATIENTS WITH RELAPSED/REFRACTORY CYTOTOXIC LYMPHOMAS: DOSE ESCALATION AND OPTIMIZATION

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	S. P. Iyer, J. Zain, N. Khan, E. Marchi, M. Gandhi, Y. H. Kim, M. S. Khoudadoust, J. C. Reneau, C. Poh, C. K. Yannakou, P. Porcu, W. S. Kim, P. L. Zinzani, K. Dilley, W. Hong, A. Kantor, R. Shi, J. Richardson, N. Tomasevic, H. M. Prince, S. M. Horwitz
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Hematological Oncology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet